Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.

Slides:



Advertisements
Similar presentations
SOMA2 – Drug Design Environment. Drug design environment – SOMA2 The SOMA2 project Tekes (National Technology Agency of Finland) DRUG2000 program.
Advertisements

1 Real World Chemistry Virtual discovery for the real world Joe Mernagh 19 May 2005.
Analysis of High-Throughput Screening Data C371 Fall 2004.
Better Than Google™ (if you are a pharmaceutical company) Professor Daniel Miranker Department of Computer Science Institute of Cell and Molecular Biology.
Jürgen Sühnel Institute of Molecular Biotechnology, Jena Centre for Bioinformatics Jena / Germany Supplementary Material:
Personalia: Pre-Sheffield Batchelor’s degree in Chemistry at Oxford Pre-university job in my local public library system Chemistry or information science?
Jeffery Loo NLM Associate Fellow ’03 – ’05 chemicalinformaticsforlibraries.
Design of Small Molecule Drugs Targeted to RNA RNA Ontology Group May
OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.
20/03/2008 Dept. of Pharmaceutics 1 APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY AND PROCESS RESEARCH Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate.
Protein Structure and Drug Discovery Workshop To be held at Monash University, Mebourne, Australia October 3 rd to 4 th 2006 Molecular Visualization Learn.
Bioinformatics Ayesha M. Khan Spring Phylogenetic software PHYLIP l 2.
Important Points in Drug Design based on Bioinformatics Tools History of Drug/Vaccine development –Plants or Natural Product Plant and Natural products.
Computational Techniques in Support of Drug Discovery October 2, 2002 Jeffrey Wolbach, Ph. D.
Cédric Notredame (30/08/2015) Chemoinformatics And Bioinformatics Cédric Notredame Molecular Biology Bioinformatics Chemoinformatics Chemistry.
Combinatorial Chemistry and Library Design
Asia’s Largest Global Software & Services Company Genomes to Drugs: A Bioinformatics Perspective Sharmila Mande Bioinformatics Division Advanced Technology.
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
A genetic algorithm for structure based de-novo design Scott C.-H. Pegg, Jose J. Haresco & Irwin D. Kuntz February 21, 2006.
Introduction to Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
Daniel Brown. D9.1 Discuss the use of a compound library in drug design. Traditionally, a large collection of related compounds are synthesized individually.
Use of Machine Learning in Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
20/03/2008 Dept. of Pharmaceutics 1. Use of BIOINFORMATICS in Pharmaciutics 2  Presented By  Shafnan Nazar  Hamid Nasir 
Page 1 SCAI Dr. Marc Zimmermann Department of Bioinformatics Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) Grid-enabled drug discovery.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
ECCR Overview/MLSCN. NIH Roadmap Series of initiatives designed to pursue major opportunities in biomedical research and gaps in current knowledge that.
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013.
Use of Machine Learning in Chemoinformatics
Computational Approach for Combinatorial Library Design Journal club-1 Sushil Kumar Singh IBAB, Bangalore.
Introduction It had its early roots in World War II and is flourishing in business and industry with the aid of computer.
Docking and Virtual Screening Using the BMI cluster
Molecular Modeling in Drug Discovery: an Overview
Designing Drugs Virtually P14D461P - Arni B. Hj. Morshidi P14D389P - Anisah Bt Ismail P14D397P - Syarifah Rohaya Bt Wan Idris P14D394P - Dayang Adelina.
Natural products from plants
Page 1 Bio-layer Interferometry Bio-layer Interferometry (BLI) Service by Profacgen.
Free Powerpoint Templates Page 1 Free Powerpoint Templates Electrophoretic Mobility Shift AssayElectrophoretic Mobility Shift Assay (EMSA) Service by Profacgen.
Page 1 Protein Labeling Service --Profacgen. Page 2 Site-specific labeling technique refers to the covalent attachment of molecules like biotin, fluorophore,
Free Powerpoint Templates Page 1 Free Powerpoint Templates Transporter Screening Service --Profacgen.
Page 1 Protein Crystallization and Structure Determination ---by Creative BiostructureCreative Biostructure.
Free Powerpoint Templates Page 1 Free Powerpoint Templates Protein Crystallization -by Creative Biostructure.
Page 1 Phase Determination by Creative BiostructureCreative Biostructure.
Page 1 NMR Services —by Creative Biostructure. Page 2 NMR spectroscopy is a key analytical technique for structure elucidation of a wide range of materials.
Page 1 Molecular Modeling Service in Profacgen. Page 2 The three-dimensional structure of a protein provides essential information about its biological.
Page 1 Protein Crystallization —by Creative Biostructure.
Free Powerpoint Templates Page 1 Free Powerpoint Templates Enzyme Target & Activator & Inhibitor Screening Service —Profacgen.
Lipinski’s rule of five
Dr. George Geromichalos, Ph.D.
SEMINAR 1. Title : Discovery of Protein-Protein Interaction Modulators Using Affinity-Based High-Throughput Screening 2. Speaker : Hyun-Suk Lim (포항공대 (POSTECH))
Figure 1. Biotechnology sector’s knowledge base
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Important Points in Drug Design based on Bioinformatics Tools
Protein Interaction AnalysisProtein Interaction Analysis Services Profacgen.
ADME/Tox PredictionTox Prediction. The characterization of Absorption, Distribution, Metabolism, and Excretion (also known as ADME) and Toxicity are essential.
Ligand-Based Structural Hypotheses for Virtual Screening
Page 1 Protein Ubiquitinylation — Creative BioMart.
Proteolysis Targeting Chimera Profacgen. In mammalian cells, protein degradation is mainly carried out by the ubiquitin- proteasome system to dispose.
Protein/peptide Crosslinkingpeptide Crosslinking Profacgen.
Hydrophobic Tag Services Profacgen. Despite the great progress in developing ligands to specific proteins, there are only about 300 molecular targets.
Molecular Docking Profacgen. The interactions between proteins and other molecules play important roles in various biological processes, including gene.
Virtual Screening.
“Structure Based Drug Design for Antidiabetics”
Ligand Docking to MHC Class I Molecules
Volume 19, Issue 1, Pages (January 2012)
Important Points in Drug Design based on Bioinformatics Tools
How Chemoproteomics Can Enable Drug Discovery and Development
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Presentation transcript:

Page 1 Computer-aided Drug Design —Profacgen

Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will bind to a target protein and if so how strongly. Rapid developments in the fields of combinatorial chemistry and high-throughput screening (HTS) technologies have enabled large libraries of compounds to be synthesized and screened. However, synthesizing a large number of compounds is expensive and the subsequent screening experiment can still be time-consuming. As a result, computational methods are gaining increasing popularity in drug discovery. Virtual screening (VS) represents a powerful alternative strategy for identifying hit molecules from a set of compounds in a relatively short period of time, which has already become a crucial step in early-stage drug discovery.

Page 3 Profacgen takes advantage of the most state-of-the-art VS techniques and software tools for hit and lead identification. The application of VS follows a typical sequence of processes with a cascade of sequential filters able to narrow down and choose a set of lead-like hits with potential biological activity. We offer both ligand-based virtual screening (LBVS) and structure-based virtual screening (SBVS) services.

Page 4 LBVS Biological data are explored in order to identify known active or inactive compounds that will be used to retrieve other potentially active molecular scaffolds for experimental evaluation. LBVS methods include approaches such as similarity and substructure searching, quantitative structure- activity relationships (QSAR), pharmacophore mapping, and machine learning.

Page 5 SBVS Candidate molecules are computationally docked into the three-dimensional structure of the biological target (determined either experimentally or computationally through homology modeling). These docked compounds are then ranked based on their predicted binding affinity or complementarity to the binding site, as well as other criteria. Usually only a few top-ranked compounds are selected as candidates for further experimental assays.

Page 6 Profacgen provides computer-aided drug design service that enables researchers to effectively screen drug design space and identify most promising candidates. Our optimized protocol reduces the size of chemical library to be screened experimentally, increases the likelihood to find innovative hits in a faster and less expensive manner, and mitigate the risk of failure in the lead optimization process due to absorption, distribution, metabolism, excretion and toxicity deficiencies.computer-aided drug design

Page 7 Contact Profacgen Address: 45-1 Ramsey Road Shirley, NY 11967, USA Website: